Suppr超能文献

一种利用生物发光成像技术的胶质瘤生长和侵袭筛选平台。实验室研究。

A screening platform for glioma growth and invasion using bioluminescence imaging. Laboratory investigation.

作者信息

Zhao Hong, Tang Carol, Cui Kemi, Ang Beng-Ti, Wong Stephen T C

机构信息

Department of Radiology, The Methodist Hospital and The Center for Biotechnology and Informatics, The Methodist Hospital Research Institute, Weill Medical College, Cornell University, Houston, Texas 77030, USA.

出版信息

J Neurosurg. 2009 Aug;111(2):238-46. doi: 10.3171/2008.8.JNS08644.

Abstract

OBJECT

The study of tumor cell growth and invasion in cancer biology is often limited by the inability to visualize tumor cell behavior in real time in animal models. The authors provide evidence that glioma cells are heterogeneous,with a subset responsible for increased invasiveness. The use of bioluminescence (BL) imaging to investigate dynamic aspects of glioma progression are discussed.

METHODS

Glioblastoma multiforme-initiating cells were generated under conditions typically used to sustain neural stem cells. The invasiveness potential was determined using a Matrigel chamber. The presence of an "invasiveness gene signature" that correlated with patient survival outcome was ascertained through microarray gene expression analysis. To measure invasiveness, the authors devised a method focussed on BL imaging and tested it in vitro and in vivo using a zebrafish xenograft model. Bioluminescence imaging signals were verified using known inhibitors of glioma growth: AEE788, N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester, and compound E.

RESULTS

The authors' data support the idea that glioblastoma multiforme-initiating cells are heterogeneous and possess an invasive subset; BL imaging was used as a readout method to assess this invasive subset. The in vitro data obtained using a known glioma growth inhibitor, AEE788, showed that BL imaging could detect cellular movement and invasion even before overall cell death was detectable on conventional viability assays. Further work using a zebrafish tumor xenograft model supported the efficacy of BL imaging in monitoring changes in tumor load.

CONCLUSIONS

The authors used optically transparent zebrafish and high-resolution confocal imaging to track tumor growth in vivo and demonstrate the efficacy of this model for screening antitumor and antiangiogenic compounds.The integration of zebrafish transgenic technology into human cancer biological studies may aid in the development of cancer models targeting specific organs, tissues, or cell types within tumors. Zebrafish could also provide a cost-effective means for the rapid development of therapeutic agents directed at blocking tumor growth and invasion.

摘要

目的

癌症生物学中肿瘤细胞生长和侵袭的研究常常受到无法在动物模型中实时观察肿瘤细胞行为的限制。作者提供证据表明胶质瘤细胞是异质性的,其中一部分细胞导致侵袭性增加。本文讨论了使用生物发光(BL)成像来研究胶质瘤进展的动态方面。

方法

在通常用于维持神经干细胞的条件下生成多形性胶质母细胞瘤起始细胞。使用基质胶小室测定侵袭潜能。通过微阵列基因表达分析确定与患者生存结果相关的“侵袭性基因特征”的存在。为了测量侵袭性,作者设计了一种基于BL成像的方法,并在体外和体内使用斑马鱼异种移植模型对其进行测试。使用已知的胶质瘤生长抑制剂:AEE788、N-[(3,5-二氟苯基)乙酰基]-L-丙氨酰-2-苯基甘氨酸-1,1-二甲基乙酯和化合物E验证生物发光成像信号。

结果

作者的数据支持多形性胶质母细胞瘤起始细胞是异质性的且具有侵袭性子集这一观点;BL成像被用作评估该侵袭性子集的读出方法。使用已知的胶质瘤生长抑制剂AEE788获得的体外数据表明,在传统活力测定可检测到总体细胞死亡之前,BL成像就能检测到细胞运动和侵袭。使用斑马鱼肿瘤异种移植模型的进一步研究支持了BL成像在监测肿瘤负荷变化方面的有效性。

结论

作者使用光学透明的斑马鱼和高分辨率共聚焦成像来追踪体内肿瘤生长,并证明该模型在筛选抗肿瘤和抗血管生成化合物方面的有效性。将斑马鱼转基因技术整合到人类癌症生物学研究中可能有助于开发针对肿瘤内特定器官、组织或细胞类型的癌症模型。斑马鱼还可为快速开发旨在阻断肿瘤生长和侵袭的治疗药物提供一种经济有效的手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验